Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes management, has emerged as a treatment option for chronic weight management in adults with obesity or overweight conditions. Tennessee patients now have multiple pathways to obtain compounded semaglutide without geographic barriers or insurance requirements, combining convenience with clinical oversight.

Telehealth Access to Semaglutide in Tennessee

PlexusDx provides remote consultations connecting Tennessee patients with licensed healthcare providers who evaluate medical history, current medications, and weight loss goals through video appointments. This telehealth model eliminates travel time while maintaining the clinical assessment necessary for safe medication initiation. Patients can begin treatment within days of their consultation approval, with injectable semaglutide shipped directly to their home or preferred address.

The telehealth process at PlexusDx includes a detailed intake form, virtual provider consultation, baseline health screening, and personalized treatment recommendations. Tennessee residents benefit from state-licensed provider oversight without the scheduling constraints of traditional in-office practices. Follow-up monitoring occurs through virtual visits, ensuring dose adjustments and side effect management remain accessible throughout the treatment journey.

In-Person Consultation Options for Tennessee Patients

While PlexusDx specializes in telehealth delivery, Tennessee patients seeking in-person initial evaluations can coordinate local provider visits in major cities including Nashville, Memphis, Knoxville, and Chattanooga. Many independent primary care clinics and weight management specialists partner with PlexusDx to provide hands-on assessments before initiating compounded semaglutide therapy. This hybrid approach offers patients the choice between remote convenience and face-to-face clinical interaction.

In-person visits provide opportunities for weight measurement, blood pressure monitoring, and physical examination at baseline and follow-up intervals. Patients can discuss injection technique, storage requirements, and side effect management directly with a clinician. PlexusDx coordinates prescription delivery to licensed 503A compounding pharmacies regardless of consultation setting, ensuring medication quality and regulatory compliance across all Tennessee regions.

Compounded Semaglutide Pricing and Dosing Structure

PlexusDx compounded semaglutide injections start at $149 per month, with a flat monthly rate regardless of dose escalation. This pricing model means your dose may need to go up, but your price won't, removing cost uncertainty as patients titrate toward their therapeutic range. The medication is prepared by licensed 503A compounding pharmacies meeting strict pharmaceutical standards, and patients can access treatment without health insurance or subscription memberships.

Monthly pricing includes all shipping and pharmacy preparation costs, with HSA and FSA accounts eligible for reimbursement in most cases. Tennessee patients can choose commitment tiers offering flexibility between monthly, quarterly, or semi-annual enrollment options while maintaining consistent per-month pricing. No membership fees, insurance preauthorization delays, or prior authorization requirements apply, making treatment initiation faster than traditional healthcare pathways.

Precision Genetic Testing for Personalized Semaglutide Response

PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis examining how individual genetic variants influence GLP-1 receptor sensitivity, appetite regulation, and weight management potential. Key genetic markers including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 help predict individual response patterns to semaglutide therapy. This $99 add-on test, available after the first month of treatment, maps 14 metabolic pathways and 49 peptide-related insights for truly personalized dosing strategy.

Tennessee patients benefit from genetic insights that inform whether standard semaglutide dosing aligns with their individual biology or whether alternative compounds like tirzepatide might offer superior outcomes. PlexusDx uses these 150+ genetic insights to guide provider recommendations and help patients understand their unique metabolic predispositions. This precision approach reduces trial-and-error medication adjustments while optimizing long-term treatment adherence and clinical results.

Medication Delivery and Storage in Tennessee

Compounded semaglutide from PlexusDx arrives in temperature-controlled packaging designed for safe transit across Tennessee's varying climates. Injectable semaglutide requires refrigeration between 36°F and 46°F before use, with unopened pens remaining stable for up to 28 days after first injection if proper storage conditions are maintained. PlexusDx includes detailed storage and handling instructions with each shipment, and patient support staff remain available to answer questions about medication preservation and injection technique.

All shipments to Tennessee addresses include tracking information and signature confirmation when requested. Patients receive supplies timed to ensure continuous medication access without gaps in treatment. If storage or delivery issues arise, PlexusDx customer service coordinates replacement shipments promptly, ensuring treatment consistency throughout the patient's weight management journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I get semaglutide in Tennessee without visiting a doctor's office?

Yes. PlexusDx telehealth consultations connect you with a licensed provider via video, eliminating office visits while maintaining full clinical oversight. After approval, compounded semaglutide ships directly to your Tennessee address. Many patients complete their entire initial process remotely and begin treatment within days.

What dose of semaglutide does PlexusDx offer?

PlexusDx compounded semaglutide is customized by your prescribing provider based on your health status and treatment goals. Typical titration begins at lower doses and increases gradually over weeks. Your dose may need to go up, but your price won't—the flat $149/month rate covers all dose levels.

Is PlexusDx semaglutide FDA-approved?

PlexusDx semaglutide is compounded by licensed 503A compounding pharmacies and is not FDA-approved as a brand medication. However, 503A compounding pharmacies operate under strict FDA regulation and state pharmacy board oversight. Your provider prescribes compounded semaglutide based on clinical judgment for your individual needs.

Does PlexusDx accept insurance?

No insurance is required to access PlexusDx semaglutide. Monthly pricing starts at $149 regardless of insurance status. HSA and FSA accounts are eligible for reimbursement, and many patients use these tax-advantaged accounts to reduce out-of-pocket costs.

How does the Precision Peptide Genetic Test personalize my semaglutide treatment?

The $99 test examines genetic variants affecting GLP-1 receptor function, appetite hormones, and metabolic rate. Results guide your provider on optimal dosing strategy and whether alternative compounds like tirzepatide might work better for your biology. This precision approach reduces guesswork and improves treatment outcomes.

What side effects should I expect from semaglutide?

Common side effects include nausea, vomiting, constipation, and appetite suppression, typically most pronounced during dose escalation. Most side effects diminish as your body adjusts. Your PlexusDx provider monitors your experience during follow-up visits and can adjust your dose or recommend management strategies if needed.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves